Effects of tacrolimus ointment on the expression of substance P, nerve growth factor, and neurotrophin-3 in atopic dermatitis

International Journal of Dermatology

Volumn 48, Issue 4, 2009, Pages 431-438

  Kim, Hye One ^a,b   Lee, Cheol Heon ^a,b   Ahn, Hye Kyung ^a,b   Park, Chun Wook ^a,b  

^a Hallym University   (South Korea)

^b Hallym University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; NEUROPEPTIDE; NEUROTROPHIN 3; SUBSTANCE P; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; BLOOD LEVEL; BLOOD SAMPLING; CELL COUNT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DERMIS; EPIDERMIS; FEMALE; HUMAN; IMMUNOCOMPETENT CELL; MALE; OINTMENT; PATHOGENESIS; SCHOOL CHILD; SKIN BIOPSY; SKIN DEFECT; TISSUE LEVEL;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; BIOPSY; CHILD; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; NERVE FIBERS; NERVE GROWTH FACTOR; NEUROTROPHIN 3; SKIN; SUBSTANCE P; TACROLIMUS; YOUNG ADULT;

EID: 63249117899     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.03968.x     Document Type: Article

References (23)

1. Steinhoff M, Stander S, Seeliger S, et al. Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol 2003; 139: 1479-1488.
2. Misery L. Skin, immunity and the nervous system. Br J Dermatol 1997; 137: 843-850.
3. Stander S, Steinhoff M. Pathophysiology of pruritus in AD: An overview. Exp Dermatol 2002; 11: 12-24.
4. Ostlere LS, Cowen T, Rustin MH. Neuropeptides in the skin of patients with atopic dermatitis. Clin Exp Dermatol 1995; 20: 462-467.
5. Tobin D, Nabarro G, Baart de la Faille H, et al. Increased number of immunoreactive nerve fibers in atopic dermatitis. J Allergy Clin Immunol 1992; 90: 613-622.
6. Sugiura H, Omoto M, Hirota Y, et al. Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis. Arch Dermatol Res 1997; 289: 125-131.
7. Toyoda M, Nakamura M, Makino T, et al. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002; 147: 71-79.
8. Groneberg DA, Serowka F, Peckenschneider N, et al. Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1. J Neuroimmunol 2005; 161: 87-92.
9. Metz M, Botchkarev VA, Botchkareva NV, et al. Neurotrophin-3 regulates mast cell functions in neonatal mouse skin. Exp Dermatol 2004; 13: 273-281.
10. Botchkarev VA, Metz M, Botchkareva NV, et al. Brain-derived neurotrophic factors, neurotrophin-3, and neurotrophin-4, act as 'epitheliotrophins'in murine skin. Lab Invest 1999; 79: 557-572.
11. Andoh T, Kuraishi Y. Nitric oxide enhances substance P-induced itch-associated responses in mice. Br J Pharmacol 2003; 138: 202-208.
12. Senba E, Katanosaka K, Yajima H, et al. The immunosuppressant FK506 activates capsaicin- and bradykinin-sensitive DRG neurons and cutaneous C-fibers. Neurosci Res 2004; 50: 257-262.
13. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Suppl.) (Stockh) 1980; 92: S44-s47.
14. Hanifin JM, Ling MR, Langley R, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy. J Am Acad Dermatol 2001; 44 (Suppl. 1): S28-S38.
15. Won CH, Seo PG, Park YM, et al. A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea. J Dermatol Treat 2004; 15: 30-34.
16. Zuber M, Donnerer J. Effect of FK506 on neurotransmitter content and expression of GAP-43 in neurotoxin-lesioned peripheral sensory and sympathetic neurons. Pharmacology 2002; 66: 44-50.
17. Yokote R, Yagi H, Furukawa F, et al. Regulation of peripheral blood mononuclear cell responses to Dermatophagoides farinae by substance P in patients with atopic dermatitis. Arch Dermatol Res 1998; 290: 191-197.
18. Lonne-Rahm S, Berg M, Marin P, et al. Atopic dermatitis, stinging, and effects of chronic stress: A pathocausal study. J Am Acad Dermatol 2004; 51: 899-905.
19. Tanaka K, Fujita N, Higashi Y, et al. Neuroprotective and antioxidant properties of FKBP-binding immunophilin ligands are independent of the FKBP12 pathway in human cells. Neurosci Lett 2002; 330: 147-150.
20. Yonehara N, Yoshimura M. Effect of nitric oxide on substance P release from the peripheral endings of primary afferent neurons. Neurosci Lett 1999; 271: 199-201.
21. Sieber-Blum M, Szeder V, Grim M. The role of NT-3 signaling in Merkel cell development. Prog Brain Res 2004; 146: 63-72.
22. Lan CC, Kao YH, Huang SM, et al. FK506 independently upregulates transforming growth factor beta and downregulates inducible nitric oxide synthase in cultured human keratinocytes: Possible mechanisms of how tacrolimus ointment interacts with atopic skin. Br J Dermatol 2004; 151: 679-684.
23. Yosipovitch G. Itching in the new millennium: Highlights of the Second International Workshop for the Study of Itch, Toyoma, Japan. J Am Acad Dermatol 2004; 51: 625-627.